Scott B. Ullem, CVP, Chief Financial Officer at Edwards Lifesciences Corp (EW), sold 11,250 shares at $90.45 ($1.0M) on 2024-05-21, disclosed to the SEC on 2024-05-21.
Scheduled sale ($1.0M) by CVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.45 | 5,625 | $509K | 50.0% |
| 2 | $90.45 | 5,625 | $509K | 50.0% |
| Total | $90.45 avg | 11,250 | $1.0M | 100% |
| Filing → |
| EW | SELL | 2025-12-09 | $650K | — | Filing → |
| EW | SELL | 2025-11-10 | $2.2M | — | Filing → |
| EW | SELL | 2025-05-09 | $1.7M | — | Filing → |